Code : |
3KNX
PDBj
RCSB PDB
PDBe
|
Title : |
HCV NS3 protease domain with P1-P3 macrocyclic ketoamide inhibitor |
Release Data : |
2010-10-27 |
Compound : |
mol_id |
molecule |
chains |
|
1 |
HCV NS3 Protease
|
A,C
|
|
|
fragment: Protease domain, UNP residues 1027-1207
|
mol_id |
molecule |
chains |
|
2 |
HCV NS4a peptide
|
B,D
|
|
|
fragment: UNP residues 1678-1696
mutation: C28S
|
|
Source : |
mol_id |
organism_scientific |
expression_system
|
|
1 |
Hepatitis C virus subtype 1a
(taxid:63746)
|
Escherichia coli
(taxid:562)
|
|
|
strain: H77 Strain of genotype 1a
gene: NS3
expression_system_strain: BL21(DE3)
expression_system_vector_type: pET-3a
|
mol_id |
organism_scientific |
|
|
2 |
|
|
|
|
synthetic: yes
other_details: Peptides were synthesized using Fmoc solid-phase chemistry on an ABI 431 synthesizer (Foster City, CA). Preloaded 2-chlorotrityl chloride resin or Wang resin was used for the solid phase assembly of NS4A activator peptide. The sequence of the peptide was Lys-Lys-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg-Pro-Ala-Ile-Val-Pro-Lys-Lys-OH. Trifunctional residue sidechain protecting groups included tert-butyl for Ser, tert-butoxycarbonyl for Lys, and 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl for Arg. Cleavage and sidechain deprotection was accomplished using 92.5% trifluoroacetic acid, with 2.5% each of water, ethanedithiol and triisopropylsilane for 2 hours. The peptide was purified by reversed phase HPLC. The peptide molecular weight was confirmed by electrospray ionization mass spectrometry.
|
|
Authors : |
Venkatraman, S., Velazquez, F., Wu, W., Blackman, M., Chen, K.X., Bogen, S., Nair, L., Tong, X., Chase, R., Hart, A., Agrawal, S., Pichardo, J., Prongay, A., Cheng, K.-C., Girijavallabhan, V., Piwinski, J., Shih, N.-Y., Njoroge, F.G. |
Keywords : |
Hepatitis C Virus, NS3 Protease Domain, serine protease, macrocyclic ketoamide inhibitor, ATP-binding, Envelope protein, Helicase, Hydrolase, Membrane, Nucleotide-binding, RNA replication, Transmembrane, VIRAL PROTEIN |
Exp. method : |
X-RAY DIFFRACTION ( 2.65 Å ) |
Citation : |
Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
Venkatraman, S.,Velazquez, F.,Wu, W.
et al.
(2009)
J.Med.Chem.
52
: 336
- 346
PubMed: 19102654
DOI: 10.1021/jm800940u
|